Individual metabolic characteristics, including baseline insulin sensitivity, body mass index, and the presence of prediabetes or type 2 diabetes, appear to influence incretin hormone secretion patterns
He also noted that the benefits of these adjunctive therapies on blood glucose management and kidney- and heart-related disease reduction are well-documented, and that several major medical organizations, like the American Heart Association and American Society of Nephrology, have even changed their guidelines to include these medications
Napoli R, Berra C, Catarig AM, Di Loreto C, Donatiello E, Berentzen TL, et al
The emergence of GLP-1R as a popular target for weight loss is mainly attributed to its mechanistic features and the weight reduction efficacy shown by liraglutide and semaglutide
When it comes to weight loss, the battle often calls for reinforcements beyond diet and exercise